The European Court of Justice has confirmed that financial investors can incur parental liability for the anticompetitive practices of portfolio companies, even after an IPO that left the investor holding only a minority...more
On 12 December 2018, the General Court (“Court”) partially annulled the European Commission’s decision of 9 July 2014 in the Servier case and consequently reduced Servier’s fine by more than 30%, from €330.99 million to...more
12/21/2018
/ Abuse of Dominance ,
Annulment ,
Anti-Competitive ,
Antitrust Violations ,
EU ,
European Commission ,
European Patent Office ,
Fee Reductions ,
General Court of the European Union (GCEU) ,
Generic Drugs ,
IP License ,
Patent Validity ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Reverse Payment Settlement Agreements ,
Settlement Agreements ,
Treaty on the Functioning of the European Union (TFEU)
The General Court of the European Union recently held, in Goldman Sachs v. Commission, that purely financial investors such as investment funds may be held jointly and severally liable for competition law violations...more
9/25/2018
/ Anticompetitive Behavior ,
Antitrust Violations ,
Appeals ,
Board of Directors ,
Cartels ,
EU ,
European Commission ,
Financial Adviser ,
General Court of the European Union (GCEU) ,
Goldman Sachs ,
Initial Public Offering (IPO) ,
Investment Funds ,
Investors ,
Joint and Several Liability ,
Market-Sharing ,
Parent Corporation ,
Portfolio Companies ,
Private Equity ,
Subsidiaries